Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conatumumab and Panitumumab in Metastatic Colorectal Cancer
NCT00630786Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2008
- Primary completion
- May 2009
01
Overview
A Phase 2 trial of conatumumab in colorectal cancer (metastatic) (mCRC), sponsored by Amgen. Started Jan 2008; status: completed.
02
Drugs
conatumumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00630786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630786.